Archives: Speakers

Arno Ružička, project manager, is a graduate electrical engineer and expert in industrial automation with over 15 years of experience. He specializes in developing and implementing software solutions that modernize industrial processes, particularly in the brewing and food industries, as well as across other manufacturing sectors.

Pablo Cano Trilla leads the legal analysis team at Tamarind Intelligence (publisher of ECigIntelligence and TobaccoIntelligence), overseeing regulatory coverage across more than 100 countries, U.S. states, and other subnational jurisdictions.

He holds a Master of Laws (LLM) with Distinction from the University of Aberdeen and degrees in law and political science. Pablo began his career as an assistant at the European Parliament and has since built an international legal career, working as a lawyer and legal analyst in Mexico, the UK, and Spain, specializing in highly regulated industries. He is a qualified attorney.

For over a decade, Pablo has provided independent, in-depth legal and political analysis on the tobacco and nicotine industries to clients including international corporations, governments, tobacco control NGOs, and academic institutions. A seasoned speaker, he has delivered numerous presentations and conferences on key industry issues to diverse global audiences.

Dr. Manley is Chief of Neurosurgery at Zuckerberg San Francisco General Hospital and Professor and Vice Chairman of Neurological Surgery at UCSF. Dr. Manley’s research interests range from molecular aspects of traumatic brain injury (TBI) to the clinical care of TBI victims. This work spans from the laboratory to the bedside in an effort to develop translational models and data repositories to improve the diagnosis, prognosis and treatment of mild to severe brain injuries.

My professional career spans three decades in the pharmaceutical industry. My journey began as a law firm paralegal for several years before entering the pharmaceutical industry through Blis-tech, where I held a range of roles and responsibilities, including Quality Assurance, Technical Design, Project Management, Distribution, and Contracts Management.  Upon that success, I established a consulting role at Jeiven Pharmaceutical Consulting, overseeing a project management group for three years. Since then, I have been an integral part of the Otsuka company for over 20 years.  Currently, the Director of Clinical Supplies Operations, overseeing the Clinical Supply Operations for global packaging, labeling, and logistics, directs the RTSM/IRT, and the overall various integration programs, on the use of seamless, integrated systems for superior trial management and results.

Michael MacNeir is the VP of Business Development at Sharp Clinical Services, where he leads commercial strategy and client partnerships across clinical trial supply chain solutions. With a long-standing career in the clinical supply services industry, he works closely with his team to support pharma and biotech sponsors to build integrated packaging, manufacturing, and global distribution solutions that support clinical development from early phase through late stage.

Steve Jacobs, R.Ph., is the President of Global BioPharm Solutions and a veteran executive with 30+ years of experience in clinical supply chain and global logistics. He is a trainer and consultant, on both the R&D supply chain and commercial operations enhancement, to Biotech and Pharmaceutical organizations worldwide. Steve previously led clinical operations for Johnson & Johnson. He currently serves on the Board of the Global Clinical Supplies Group (GCSG), specializing in operational excellence and high-performing team leadership.

Karen is Senior Director of Clinical Pharmacology Solution Consulting for Parexel. She has over 20 years of progressive experience in the CRO industry with a strong background in early drug development and clinical pharmacology.

With a comprehensive understanding of Phase I study design, feasibility, clinical execution, regulatory requirements, and non-clinical services, she brings a straightforward, analytical and solution-orientated approach to strategy and proposal delivery.

Enthusiastically supporting drug development from first-in-human through proof-of-concept across a global clinical site network, she crafts compelling operational, technical and business strategies; showing innovation, financial acumen and general management competencies to support current and future client needs.